← Open Payments lookup

STEPHANE GANHYM: Open Payments

NPI 1073120572 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$796 in 37 payments from 9 companies in 2025. Trend: 2023 $334 · 2024 $419 · 2025 $796

Food & beverage: $796
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.9$146
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$120
Vanda Pharmaceuticals Inc.3$100
Teva Pharmaceuticals USA, Inc.4$96
Alkermes, Inc.5$94
Lundbeck LLC4$77
Neurocrine BioSciences, Inc.2$61
ABBVIE INC.3$55
Otsuka America Pharmaceutical, Inc.2$47

Products named: COBENFY, ABILIFY ASIMTUFII, CAPLYTA, ARISTADA, UZEDY, FANAPT, INGREZZA, VRAYLAR.

Industry payments across DC — which companies pay providers there.